IPEXR dividend yield: 4.00%. PFE dividend yield: 6.77%. IPEXR is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in IPEXR shares. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
IPEXR is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in IPEXR shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
Is IPEXR or PFE better for dividend income in 2026?
IPEXR currently offers a 4.00% yield (2.00/share/year) while PFE offers 6.77% (1.68/share/year). PFE provides higher current income. However, IPEXR has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in IPEXR vs PFE earn per year?
With $10,000 invested today: IPEXR pays approximately $400/year. PFE pays approximately $677/year. With DRIP reinvestment over 10 years, these grow to $899/year (IPEXR) and $5,820/year (PFE).
Does IPEXR or PFE pay monthly dividends?
IPEXR pays quarterly dividends. PFE pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this IPEXR vs PFE comparison by email
Save your analysis + get weekly dividend insights. Free forever.